HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Tackles Obesity With Nutraceuticals Guidance, Warning Letters

This article was originally published in The Tan Sheet

Executive Summary

A string of warning letters issued by FDA to several dietary supplement companies making weight loss products is being billed as part of the agency's aggressive effort to combat obesity

You may also be interested in...



Supplement Enforcement Momentum To Continue Under FDA Plan – Crawford

FDA expects any future dietary supplement bans to move more quickly than the ban on ephedra, according to Acting Commissioner Lester Crawford, PhD

Natrol Carb Intercept Ad Claims Require Further Scientific Backing – NAD

Natrol should discontinue claims that its Carb Intercept Phase 2 starch blocker is "scientifically proven to neutralize starch," according to the National Advertising Division

Supplements For Smokers, Alcohol Users Targeted For FDA Enforcement

Dietary supplements marketed to smokers and drinkers are two of nine categories of products that "warrant close scrutiny" for enforcement, FDA says

Topics

UsernamePublicRestriction

Register

RS128028

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel